These results demonstrate a negative interaction between acetylation and sumoylation of GCM1 in IUGR placentae, which – based on the in vitro studies and the ex vivo analysis of human placentae – appears to be regulated by p45 NF-E2 expression (Figure 8). The gene discussed is GCM1; the disease is fetal growth restriction.